ReNeuron says stem cells improved motor function in stroke study

Another breakthrough awaits human kind as Stanford health physicians take on a new challenge and research trial on stem cell therapy. Stem cells that are derived from fat tissue will be tested and checked if it can work as an alternative to surgery.

This cell trial is approved by the Food and Drug Administration agency. It is the first to involve fat-derived stem cells. It works by using a liposuction to extract the fat tissue from the abdomen. The fat tissues will then be treated with a special enzyme and will be subjected to centrifuge to separate the stem cells.

The clinical trial will involve the body's natural healing process to heal shoulder injuries. Some people sometimes refer to shoulder concerns as a tooth ache which is likened to a dull pain that seems to stay. It is known that when a person reaches 45, the tendons go through a wear and tear process that causes small tears causing the pain as per KDLT News.

Adult stem cells will be used and not embryonic stem cells. Since adipose also known as fat stem cells are to be used, the same concept will be tested. The trial of the stem cell therapy will be done to those with torn rotator cuffs, Inforum reports.

Rotator cuff injury is a common condition experienced by Americans. This has sent over 6 million patients for surgical repairs by orthopedic surgeons yearly. The trial will be an opportunity to change the type of treatment done to those with rotated cuff injuries.

The result will be evaluated through a high-resolution MRI image along with an evaluation of the person's shoulder status in terms of strength, range of motion and perception of pain. Once the test turns out to be successful, stem cell therapy that is fat-derived will most likely be performed in a broad range of tissue repairs.

Source: https://goo.gl/Sv3MXX

Comments

Lab-Grown Blood Stem Cells Produced at Last

After 20 years of trying, scientists have transformed mature cells into primordial blood cells that regenerate themselves and the components of blood. The work, described today in Nature, offers hope to people with leukaemia and other blood disorders who need bone-marrow transplants but can’t find a compatible donor. If the findings translate into the clinic, these patients could receive lab-grown versions of their own healthy cells. One team, led by stem-cell biologist George Daley of Boston Children’s Hospital in Massachusetts, created human cells that act like blood stem cells, although they are not identical to those found in nature. A second team, led by stem-cell biologist Shahin Rafii of Weill Cornell Medical College in New York City, turned mature cells from mice into fully fledged blood stem cells. “For many years, people have figured out parts of this recipe, but they’ve never quite gotten there,” says Mick Bhatia, a stem-cell researcher at McMaster University i...

Mesentery: New organ discovered inside human body by scientists

A new organ has been discovered hiding in plain sight inside the human body . Known as the mesentery, it was previously thought to be just a few fragmented structures in the digestive system. But scientists have realised it is in fact one, continuous organ. Although its function is still unclear, the discovery opens up “a whole new area of science,” according to J Calvin Coffey, a researcher at the University Hospital Limerick who first discovered it. "When we approach it like every other organ… we can categorise abdominal disease in terms of this organ," he said. “Now we have established anatomy and the structure. The next step is the function. If you understand the function you can identify abnormal function, and then you have disease. “Put them all together and you have the field of mesenteric science.” The research has been published in The Lancet medical journa...

US Moves to Shut Down 2 Big Stem Cell Therapy Clinics

Federal authorities Wednesday moved to shut down two of the country’s most prominent for-profit providers of stem cell therapy, one of them a network of clinics with more than 100 offices in the United States, including several in the Bay Area. The Food and Drug Administration filed two complaints in federal court requesting permanent injunctions that would stop Florida-based U.S. Stem Cell Clinic and the California Stem Cell Treatment Center from marketing therapies. Both companies have previously been called out by the FDA for providing unproven, unapproved therapies that could put patients at risk. The injunction requests are an aggressive move by the FDA to patrol the consumer stem cell market. The agency has come under mounting pressure by scientists and patient advocates to increase oversight of the growing consumer market, which has been allowed to flourish for years. “In the two cases filed today, the clinics and their leadership have continued to disregard th...

Stem Cells Therapy in India

Search This Blog